K Pharma,Inc.
4896.T · JPX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | ¥7,206 | ¥8,355 | ¥8,836 | ¥10,946 |
| - Cash | ¥2,268 | ¥3,266 | ¥1,337 | ¥189 |
| + Debt | ¥0 | ¥0 | ¥0 | ¥0 |
| Enterprise Value | ¥4,938 | ¥5,089 | ¥7,499 | ¥10,758 |
| Revenue | ¥0 | ¥1,000 | ¥0 | ¥0 |
| % Growth | -100% | – | – | – |
| Gross Profit | ¥0 | ¥910 | ¥0 | -¥7 |
| % Margin | – | 91% | – | – |
| EBITDA | -¥844 | ¥366 | -¥391 | -¥222 |
| % Margin | – | 36.6% | – | – |
| Net Income | -¥846 | ¥260 | -¥392 | -¥229 |
| % Margin | – | 26% | – | – |
| EPS Diluted | -72.94 | 22.43 | -42.06 | -19.79 |
| % Growth | -425.2% | 153.3% | -112.5% | – |
| Operating Cash Flow | -¥984 | ¥454 | -¥363 | -¥196 |
| Capital Expenditures | -¥14 | -¥10 | -¥30 | ¥0 |
| Free Cash Flow | -¥998 | ¥445 | -¥393 | -¥196 |